Cargando…
Identification of hub miRNA biomarkers for bladder cancer by weighted gene coexpression network analysis
Bladder cancer (BC) is a common urinary system tumor with high aggressiveness, and it results in relatively high mortality due to a lack of precise and suitable biomarkers. In this study, we applied the weighted gene coexpression network analysis method to miRNA expression data from BC patients, and...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5702163/ https://www.ncbi.nlm.nih.gov/pubmed/29200870 http://dx.doi.org/10.2147/OTT.S146479 |
_version_ | 1783281469856153600 |
---|---|
author | Zhao, Feng Ge, Yu-Zheng Zhou, Liu-Hua Xu, Lu-Wei Xu, Zheng Ping, Wen-Wen Wang, Min Zhou, Chang-Cheng Wu, Ran Jia, Rui-Peng |
author_facet | Zhao, Feng Ge, Yu-Zheng Zhou, Liu-Hua Xu, Lu-Wei Xu, Zheng Ping, Wen-Wen Wang, Min Zhou, Chang-Cheng Wu, Ran Jia, Rui-Peng |
author_sort | Zhao, Feng |
collection | PubMed |
description | Bladder cancer (BC) is a common urinary system tumor with high aggressiveness, and it results in relatively high mortality due to a lack of precise and suitable biomarkers. In this study, we applied the weighted gene coexpression network analysis method to miRNA expression data from BC patients, and screened for network modules associated with BC progression. Hub miRNAs were selected, followed by functional enrichment analyses of their target genes for the most closely related module. These hub miRNAs were found to be involved in several functional pathways including pathway in cancer, regulation of actin cytoskeleton, PI3K-Akt signaling pathway, mitogen-activated protein kinase (MAPK) signaling pathway, Wnt signaling pathway, proteoglycans in cancer, focal adhesion and p53 signaling pathway via regulating target genes. Finally, their prognostic significance was tested using analyses of overall survival. A few novel prognostic miRNAs were identified based on expression profiles and related survival data. In conclusion, several miRNAs that were critical in BC initiation and progression have been identified in this study. These miRNAs, which may contribute to a comprehensive understanding of the pathogenesis of BC, could serve as potential biomarkers for BC prognosis or as new therapeutic targets. |
format | Online Article Text |
id | pubmed-5702163 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Dove Medical Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-57021632017-11-30 Identification of hub miRNA biomarkers for bladder cancer by weighted gene coexpression network analysis Zhao, Feng Ge, Yu-Zheng Zhou, Liu-Hua Xu, Lu-Wei Xu, Zheng Ping, Wen-Wen Wang, Min Zhou, Chang-Cheng Wu, Ran Jia, Rui-Peng Onco Targets Ther Original Research Bladder cancer (BC) is a common urinary system tumor with high aggressiveness, and it results in relatively high mortality due to a lack of precise and suitable biomarkers. In this study, we applied the weighted gene coexpression network analysis method to miRNA expression data from BC patients, and screened for network modules associated with BC progression. Hub miRNAs were selected, followed by functional enrichment analyses of their target genes for the most closely related module. These hub miRNAs were found to be involved in several functional pathways including pathway in cancer, regulation of actin cytoskeleton, PI3K-Akt signaling pathway, mitogen-activated protein kinase (MAPK) signaling pathway, Wnt signaling pathway, proteoglycans in cancer, focal adhesion and p53 signaling pathway via regulating target genes. Finally, their prognostic significance was tested using analyses of overall survival. A few novel prognostic miRNAs were identified based on expression profiles and related survival data. In conclusion, several miRNAs that were critical in BC initiation and progression have been identified in this study. These miRNAs, which may contribute to a comprehensive understanding of the pathogenesis of BC, could serve as potential biomarkers for BC prognosis or as new therapeutic targets. Dove Medical Press 2017-11-22 /pmc/articles/PMC5702163/ /pubmed/29200870 http://dx.doi.org/10.2147/OTT.S146479 Text en © 2017 Zhao et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. |
spellingShingle | Original Research Zhao, Feng Ge, Yu-Zheng Zhou, Liu-Hua Xu, Lu-Wei Xu, Zheng Ping, Wen-Wen Wang, Min Zhou, Chang-Cheng Wu, Ran Jia, Rui-Peng Identification of hub miRNA biomarkers for bladder cancer by weighted gene coexpression network analysis |
title | Identification of hub miRNA biomarkers for bladder cancer by weighted gene coexpression network analysis |
title_full | Identification of hub miRNA biomarkers for bladder cancer by weighted gene coexpression network analysis |
title_fullStr | Identification of hub miRNA biomarkers for bladder cancer by weighted gene coexpression network analysis |
title_full_unstemmed | Identification of hub miRNA biomarkers for bladder cancer by weighted gene coexpression network analysis |
title_short | Identification of hub miRNA biomarkers for bladder cancer by weighted gene coexpression network analysis |
title_sort | identification of hub mirna biomarkers for bladder cancer by weighted gene coexpression network analysis |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5702163/ https://www.ncbi.nlm.nih.gov/pubmed/29200870 http://dx.doi.org/10.2147/OTT.S146479 |
work_keys_str_mv | AT zhaofeng identificationofhubmirnabiomarkersforbladdercancerbyweightedgenecoexpressionnetworkanalysis AT geyuzheng identificationofhubmirnabiomarkersforbladdercancerbyweightedgenecoexpressionnetworkanalysis AT zhouliuhua identificationofhubmirnabiomarkersforbladdercancerbyweightedgenecoexpressionnetworkanalysis AT xuluwei identificationofhubmirnabiomarkersforbladdercancerbyweightedgenecoexpressionnetworkanalysis AT xuzheng identificationofhubmirnabiomarkersforbladdercancerbyweightedgenecoexpressionnetworkanalysis AT pingwenwen identificationofhubmirnabiomarkersforbladdercancerbyweightedgenecoexpressionnetworkanalysis AT wangmin identificationofhubmirnabiomarkersforbladdercancerbyweightedgenecoexpressionnetworkanalysis AT zhouchangcheng identificationofhubmirnabiomarkersforbladdercancerbyweightedgenecoexpressionnetworkanalysis AT wuran identificationofhubmirnabiomarkersforbladdercancerbyweightedgenecoexpressionnetworkanalysis AT jiaruipeng identificationofhubmirnabiomarkersforbladdercancerbyweightedgenecoexpressionnetworkanalysis |